Pulmicort

This page contains recent news articles, when available, and an overview of Pulmicort but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Pulmicort
(when available)

Pharmacology and use:
Budesonide is a synthetic corticosteroid indicated for the treatment of mild to moderate active Crohn's disease involving the ileum and/or the ascending colon. Budesonide is used in Crohn's disease to decrease the symptoms and inflammation associated with the disease, especially at times of flare up. Budesonide has a high topical glucocorticosteroid (GCS) activity and a substantial first pass elimination. The formulation contains granules which are coated to protect dissolution in gastric juice, but which dissolve at pH >5.5, ie, normally when the granules reach the duodenum. Thereafter, a matrix of ethylcellulose with budesonide controls the release of the drug into the intestinal lumen in a time-dependent manner. For the treatment of mild to moderate active Crohn's disease.

Mechanism Of Action:
The exact mechanism of action of budesonide in the treatment of Crohn's disease is not fully understood. However, being a glucocorticosteroid, budesonide has a high local anti-inflammatory effect.

News Articles on Budesonide

AstraZeneca: Apotex Barred From Launching Pulmicort Respules  -  ‎Apr 16, 2009‎
...from launching a generic version of its PULMICORT RESPULES until further order of the court. On Apr. 27, the court will commence a hearing to determine Wall Street Journal

AstraZeneca files lawsuit against Apotex over asthma drug  -  ‎Apr 7, 2009‎
AstraZeneca has begun legal proceedings against Aptoex seeking a declaration of patent infringement regarding its asthma treatment, Pulmicort respules. Hays Pharma

Apotex Wins Approval to Copy AstraZeneca’s Pulmicort  -  ‎Apr 3, 2009‎
The approval surprised investors who thought the threat to Pulmicort had ended after AstraZeneca’s November settlement with Teva Pharmaceutical Industries Bloomberg

AstraZeneca wins Pulmicort legal decision  -  ‎Apr 18, 2009‎
By John O'Doherty AstraZeneca has won a legal battle in the US temporarily preventing the launch of a generic version of Pulmicort Respules, its childhood Financial Times

Barclays and Lloyds climb ahead of Citigroup figures  -  ‎Apr 17, 2009‎
Pharmaceuticals group AstraZeneca has slipped 13p to £23.82 despite announcing an interim court victory against a generic manufacturer of its pulmicort guardian.co.uk

Business in the courts  -  ‎Apr 12, 2009‎
AstraZeneca PLC asked a US court to stop generic-drug maker Apotex Inc. from selling copies of the asthma drug Pulmicort Respules. The News Journal

MARKET COMMENT: London Stocks End Up On Citigroup, GE  -  ‎Apr 17, 2009‎
New Jersey has granted its request for a temporary restraining order barring Apotex from launching a generic version of its Pulmicort Respules medicine. Wall Street Journal

A Single Inhaler for Your Asthma  -  ‎Apr 16, 2009‎
Most asthma patients use their maintenance asthma inhaler, most commonly an inhaled steroid like Pulmicort or Flovent, and a separate rescue inhaler like About - News & Issues

More good news from the US has banks driving share market gains ...  -  ‎Apr 17, 2009‎
...granted a temporary restraining order barring Apotex from selling a generic version of AstraZeneca's lucrative Pulmicort Respules asthma medicine. Daily Mail

AstraZeneca a Hold for Now  -  ‎Apr 13, 2009‎
The company is facing a number of challenges as it enters 2009, most notably generic competition to Toprol-XL, Nexium, Casodex and Pulmicort. Zacks.com

Analyses - AstraZeneca: Crédit Suisse à sous-pondérer  -  ‎Apr 7, 2009‎
Pulmicort respules: Late on Friday FDA announced that Apotex has received US approval for generic Pulmicort respules. We understand (from AZN) that Apotex Bolsamania.fr

Business news in brief  -  ‎Apr 18, 2009‎
...company's request for a temporary restraining order barring Apotex Inc. from launching a generic version of its Pulmicort respules, which treat asthma. Philadelphia Inquirer

Woman robbed of asthma medication  -  ‎Apr 6, 2009‎
Police said the purse contained Apo-Risperidone, Apo-Bromocriptine Mesylate, Pulmicort Turbuhaler Budesonide, an asthma puffer and Bricanyl puffer. Winnipeg Sun

Mylan and Schering-Plough settle patent dispute  -  ‎Apr 9, 2009‎
...week commenced legal proceedings against Apotex over its application to market a generic version of the Anglo-Swiss firm's asthma treatment, Pulmicort. Hays Pharma

Biotech/Pharma Docket  -  ‎Apr 15, 2009‎
AstraZeneca originally filed suit on March 31, 2009, upon Apotex's announced intention to market a generic version of AstraZeneca's Pulmicort® Resulpules on Patent Docs

AstraZeneca, Lloyds, RBS, Shell: UK, Irish Equity Preview  -  ‎Apr 16, 2009‎
AstraZeneca Plc (AZN LN): The UK's second-largest drugmaker won a bid to temporarily block Apotex Inc. from selling copies of the asthma drug Pulmicort Bloomberg

Tuesday's news and tips  -  ‎Apr 7, 2009‎
AstraZeneca has filed a lawsuit in the US against Canadian firm Apotex in an attempt to try and stop it selling a generic version of Astra's Pulmicort Investors Chronicle

Lloyds down on OFT news  -  ‎Apr 7, 2009‎
AstraZeneca has filed a lawsuit in the US against Canadian firm Apotex in an attempt to try and stop it selling a generic version of Astra's Pulmicort Economy News

Amgen to present preclinical oncology data; Analysts speculate on ...  -  ‎Apr 17, 2009‎
A US court gave the drugmaker a restraining order that bars Apotex from selling a copycat version of AstraZeneca's top-selling asthma medicine Pulmicort FierceBiotech

Market Report -- In Play ()  -  ‎Apr 17, 2009‎
...for a temporary restraining order, barring Apotex from launching a generic version of AstraZeneca's PULMICORT RESPULES until further order of the court. MSN Money

* Vodafone, BT gain on positive broker notes * Defensive tobacco ...  -  ‎Apr 17, 2009‎
Thursday granted a temporary restraining order barring Apotex from selling a generic version of AstraZeneca's lucrative Pulmicort Respules asthma medicine. guardian.co.uk

astrazeneca: Court Grants Restraining Order Against Apotex  -  ‎Apr 17, 2009‎
...of New Jersey granted its request for a temporary restraining order barring Apotex from launching a generic version of its Pulmicort Respules medicine. FOXBusiness

Friday's news and tips  -  ‎Apr 17, 2009‎
Canadian generic drug specialist Apotex from launching a generic version of drug giant AstraZeneca's asthma treatment for children Pulmicort Respules. Investors Chronicle

Broker tips: BT, Tesco, AstraZeneca  -  ‎Apr 17, 2009‎
...drug giant AstraZeneca's asthma treatment for children Pulmicort Respules, prompting Panmure Gordon to reiterate its recommendation to buy the shares. ShareCast

Markets: FTSE 100 finishes on a high  -  ‎Apr 17, 2009‎
09:44 - The world's second largest drugmaker, astrazeneca (AZN), has won a temporary block on Apotex's selling of the asthma drug Pulmicort Respules. Interactive Investor

AstraZeneca Files Lawsuit Against Apotex  -  ‎Apr 7, 2009‎
The lawsuit follows Apotex's indication of intent to market a generic version of AstraZeneca's Pulmicort Respules in the US prior to the expiration of FOXBusiness

CORRECT: EARNINGS PREVIEW: European Drug Cos' 1Q  -  ‎Apr 9, 2009‎
...is unable to prevent Canadian generics drugmaker Apotex from launching its cheaper version of children's asthma treatment Pulmicort Respules. EasyBourse.com

Zacks Analyst Blog Highlights: Lattice Semiconductor, Moog Inc ...  -  ‎Apr 14, 2009‎
The company is facing a number of challenges as it enters 2009, most notably generic competition to Toprol-XL, Nexium, Casodex and Pulmicort. Business Wire (press release)

Zacks Analyst Blog Highlights: Lattice Semiconductor, Moog Inc ...  -  ‎Apr 14, 2009‎
The company is facing a number of challenges as it enters 2009, most notably generic competition to Toprol-XL, Nexium, Casodex and Pulmicort. Trading Markets (press release)

AstraZeneca erringt Etappensieg im Patentstreit mit Apotex  -  ‎Apr 17, 2009‎
Der Wettbewerber darf somit seine generische Version von Pulmicort Respules in den USA zunächst nicht vermarkten. Pulmicort Respules ist ein Medikament zur Frankfurter Allgemeine Zeitung

AstraZeneca: un générique d'Apotex temporairement interdit.  -  ‎Apr 17, 2009‎
AstraZeneca avait déposé une plainte aux Etats-Unis en mars contre la société Apotex, l'accusant de violation de brevet de Pulmicort Respules. Cercle Finance

Astras Pulmicort möter generikakonkurrens  -  ‎Apr 3, 2009‎
..."Efter att Apotex nu oväntat fått ett fullt godkännande, och om bolaget beslutar sig för att påbörja försäljningen snart, så kan våra nuvarande estimat för Dagens Industri

花旗和GE财报超预期 英股高收1%  -  ‎Apr 17, 2009‎
...阿斯利康指出,美国新泽西地方法院已å?Œæ„?自己的一项请求,暂时é™?制Apotex推出è?¯ç‰©Pulmicort Respules的仿制å“?。这ç§?è?¯ç‰©æ˜¯é˜¿æ–¯åˆ©åº·çš„一个é‡?è¦?产å“?。 新浪网

Astra Zeneca fÃ¥r stopp pÃ¥ kopierad astmamedicin  -  ‎Apr 16, 2009‎
I fjol uppgick Astra Zenecas försäljning av Pulmicort till 982 miljoner dollar. Försäljningen av Respules-versionen stod för 90 procent av Dagens Industri

AstraZeneca: la FDA demande plus d'informations sur Symbicort  -  ‎Apr 6, 2009‎
LONDRES (Dow Jones)--AstraZeneca PLC (AZN) a fait savoir lundi que l'autorité sanitaire américaine, la Food and Drug Administration, lui avait demandé des EasyBourse.com

AstraZeneca resta in rosso nonostante giudizio favorevole Corte USA  -  ‎Apr 17, 2009‎
Distretto del New Jersey ha acconsentito alla sua richiesta di bloccare il lancio di una versione generica del suo farmaco Pulmicort da parte di Apotex. La Repubblica

ÜBERBLICK/Unternehmen - 11.30 Uhr-Fassung  -  ‎Apr 7, 2009‎
AstraZeneca wirft Apotex vor, vor dem Auslaufen des Patentschutzes eine generische Version des Asthmamedikaments Pulmicort Respules in den USA vermarkten zu Frankfurter Allgemeine Zeitung

Domstol beviljar AstraZenecas begäran om tillfälligt ...  -  ‎Apr 16, 2009‎
...lanserar en generisk version av AstraZenecas PULMICORT RESPULES (budesonid inhalationssuspension) tills domstolen ger ytterligare besked. Newsdesk (pressmeddelande)

Terugroepactie Nebuhaler  -  ‎Apr 17, 2009‎
Nebuhaler is een inhalatie hulpmiddel bedoeld voor het gebruik in combinatie met AstraZeneca's dosis aërosol Pulmicort (budesonide). apothekersnieuws.nl

미 법ì›?, '풀미코트 레스퓰' ìƒ?ì‚° 금지 명령  -  ‎Apr 16, 2009‎
...미국 법ì›?ì?€ ì•„í?¬í…?스사가 ‘풀미코트 레스퓰(Pulmicort Respules)'ì?˜ 제네릭ì?„ ìƒ?산하는 것ì?„ 제한하는 한시ì ? 금지명령ì?„ 내린다고 18ì?¼ ë°?혔다. 데일리팜

AstraZeneca verklagt Apotex wegen Patentverletzung  -  ‎Apr 7, 2009‎
AstraZeneca wirft Apotex vor, vor dem Auslaufen des Patentschutzes eine generische Version des Asthmamedikaments Pulmicort Respules in den USA vermarkten zu Frankfurter Allgemeine Zeitung

AKTIEN EUROPA/Sehr fest - Gewinne in USA und Japan - Optimismus  -  ‎Apr 6, 2009‎
Der britische Pharmakonzern will den Verkauf einer generischen Version seines Asthmamittels "Pulmicort Respules" juristisch verhindern. NZZ Online

Astra Zeneca stämmer generikatillverkare  -  ‎Apr 6, 2009‎
..."Astra Zeneca har fullt förtroende för de immateriella rättigheter som skyddar Pulmicort Respules och kommer att med kraft försvara dem", Dagens Industri

法院批准AstraZeneca所æ??å?‘出临时ç¦?止令的请求  -  ‎Apr 17, 2009‎
...纽泽西州地方法院批准AstraZeneca (AZN)æ??出法院å?‘出临时ç¦?止令的请求,ç¦?æ­¢Apotex推出AstraZenecaçš„PULMICORT RESPULESå­¦å??版,等待法院å?‘布进一步命令,4月27日, 凤凰网

Asthme : rappel des chambres d’inhalation Nes Spacer® AstraZeneca  -  ‎Apr 6, 2009‎
Celles-ci sont utilisées pour administrer la spécialité Pulmicort® à des enfants asthmatiques. « Depuis décembre 2008, quatre incidents survenus chez des Destination Santé

氣管藥容器安è£?出錯需è¦?回收  -  ‎Mar 31, 2009‎
...藥廠表示,有關儀器需é…?å?ˆæ——下的壓縮å?¸å…¥å™¨ã€ŒPulmicortã€?使用,去年在本港售出的數é‡?ä¸?足二百個,主è¦?經醫生æ??供給病人使用,公立醫院涉å?Šå…©ã€?三個。 大公報

Opel-Mutter GM schließt Insolvenz nicht aus  -  ‎Apr 5, 2009‎
...(dpa-AFX) Der britische Pharmakonzern AstraZeneca will den Verkauf einer generischen Version seines Asthmamittels „Pulmicort Respules“ juristisch verhindern Frankfurter Allgemeine Zeitung

ÜBERBLICK/Unternehmen 11.30 Uhr-Fassung  -  ‎Apr 17, 2009‎
Der Wettbewerber darf somit seine generische Version von Pulmicort Respules in den USA zunächst nicht vermarkten. Die 19 großen US-Banken werden infolge der Frankfurter Allgemeine Zeitung

花旗和GE財報超é ?期 英股高收1%  -  ‎Apr 17, 2009‎
...阿斯利康指出,美國新澤西地方法院已å?Œæ„?自己的一項請求,暫時é™?制Apotex推出藥物Pulmicort Respules的仿製å“?。這種藥物是阿斯利康的一個é‡?è¦?產å“?。 新浪網

Dramatic Strides Against Childhood Asthma  -  ‎Mar 17, 2009‎
For example, 16% were taking Pulmicort vs. 0% a decade before. Children in the latter time period were in the 53rd percentile of height for their age vs. WebMD

PREVIEW-AstraZeneca goes into battle to defend Crestor  -  ‎Mar 6, 2009‎
After seeing off the immediate threat from cheap generics to Nexium, Seroquel and Pulmicort last year, AstraZeneca is widely expected to prevail in the Reuters

MAP Pharmaceuticals/AstraZeneca: setback for budesonide  -  ‎Feb 26, 2009‎
AstraZeneca currently markets Pulmicort Respules (budesonide), the only nebulized steroid available for the treatment of asthma in children, reaching sales Pharmaceutical Business Review

Steroid Lavage Passes Test in Chronic Rhinosinusitis  -  ‎Mar 16, 2009‎
To test that, the researchers used budesonide respules (sold under the brand name Pulmicort Respules), which are small, plastic, liquid-containing devices MedPage Today

Verus Spinout Meritage Puts a New Spin on Budesonide for EE  -  ‎Mar 2, 2009‎
Budesonide is the active ingredient in AstraZeneca plc's Pulmicort, an inhaled powder or suspension for asthma, and Rhinocort, a nasal spray for allergies. Therapeutics Daily (press release) (registration)

‘Suspending asthma treatment a bad option for expectant mothers ...  -  ‎Mar 10, 2009‎
According to Firoozi, there is no correlation between taking asthma medication, such as Pulmicort or Ventolin, and any congenital birth defect. Insciences Organisation

DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical ...  -  ‎Mar 13, 2009‎
His experience in successfully developing Rhinocort Aqua and Pulmicort Turbuhaler (topical budesonide, the active ingredient in Entocort) while at Astra PR Newswire (press release)

Symbicort gains COPD indication  -  ‎Mar 4, 2009‎
A single inhaler provides the inhaled corticosteroid budesonide (Pulmicort) and the rapid and long-acting bronchodilator formoterol (Oxis). Pharmafocus

Future of new AZ asthma drug uncertain after phase III failure  -  ‎Feb 25, 2009‎
Unit Dose Budesonide (UDB) is based on the same active ingredient as AstranZeneca's blockbuster asthma drug Pulmicort, and is being developed to act faster Pharmafocus

Asthma inhalers: Which one's for you?  -  ‎Mar 2, 2009‎
Used long term to prevent asthma attacks, these medications include beclomethasone dipropionate (Qvar), fluticasone (Flovent), budesonide (Pulmicort), WTHI

StandoutStocks.com: "Stocks that Standout" picks for today are ...  -  ‎Mar 13, 2009‎
His experience in successfully developing Rhinocort Aqua and Pulmicort Turbuhaler (topical budesonide, the active ingredient in Entocort) while at Astra Insurance News Net (press release)

Les femmes enceintes asthmatiques ne doivent pas renoncer à leur pompe  -  ‎Mar 12, 2009‎
Une chose est sure: il n'existe aucune corrélation entre la prise de médicaments – que ce soit les corticostéroïdes inhalés (Pulmicort) ou les InformationHospitaliere.com

Misslyckade läkemedelsstudier för AstraZeneca  -  ‎Mar 3, 2009‎
UDB bygger på samma aktiva substans som AstraZenecas storsäljande astmamedicin Pulmicort och utvecklas för att kunna användas i mindre doser med snabbare Dagens Industri

아스트ë?¼ì œë„¤ì¹´, ‘í?¬ë ˆìŠ¤í† ' 제네릭 “ë§?ë?„ 안ë?¼â€?  -  ‎Mar 8, 2009‎
...아스트ë?¼ëŠ” ‘넥시움(Nexium)’ ‘세로퀼(Seroquel)’ ‘풀미코트(Pulmicort)’ì—? 대한 제네릭 위협ì—?서 벗어난 ì?´í›„ ë˜? 다시 특허권 ë¶„ìŸ?ì—? 휘ë§?리게 ë?¼ ë‘?통거리가 ë?˜ê³  헬스코리아뉴스

아스트ë?¼ 'í?¬ë ˆìŠ¤í† ' 제네릭 소송 시작  -  ‎Mar 6, 2009‎
...아스트ë?¼ëŠ” ‘넥시움(Nexium)', '세로퀼(Seroquel)'ê³¼ ’풀미코트(Pulmicort)'ì—? 대한 제네릭 위협ì—?서 벗어난 ì?´í›„ 다시 새로운 특허권 ë¶„ìŸ?ì—? 휘ë§?리게 ë??다. 데일리팜

Brand Names/Synonyms:
Pulmicort is also known by the following brand names and/or synonymsBidien; Budeson; Budesonide; Budesonide, Pharma; BudesonideÊ; Cortivent; Desonide; Desowen; Entocort; Entocort Ec; Micronyl; Preferid; Pulmicort; Pulmicort Nebuamp; Pulmicort Respules; Pulmicort Turbuhaler; Rhinocort; Rhinocort Aqua; Rhinocort Turbuhaler; Spirocort; Tridesilon

Drug Category:
Pulmicort is categorized under the following by the FDA: Bronchodilator Agents; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA06; ATC:D07AC09; ATC:R01AD05; ATC:R03BA02

Dosage Forms:
CAPSULE (SUSTAINED-RELEASE); METERED-DOSE (AEROSOL); SUSPENSION

Absorption:
Complete

Interactions:
Interactions for Budesonide:

Concomitant oral administration of ketoconazole (a known inhibitor of CYP3A4 activity in the liver and in the intestinal mucosa) caused an eight-fold increase of the systemic exposure to oral budesonide. If treatment with inhibitors of CYP3A4 activity (such as ketoconazole, intraconazole, ritonavir, indinavir, saquinavir, erythromycin, etc.) is indicated, reduction of the budesonide dose should be considered. After extensive intake of grapefruit juice (which inhibits CYP3A4 activity predominantly in the intestinal mucosa), the systemic exposure for oral budesonide increased about two times. As with other drugs primarily being metabolized through CYP3A4, ingestion of grapefruit or grapefruit juice should be avoided in connection with budesonide administration.





Chemical IUPAC Name:
Not Available

:
 
Web health.mongabay.com/health


Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

mongabay.com


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.


COPYRIGHT 2007 MONGABAY.COM